Values as of: 2025-06-05
COMMON STOCK | Agricultural Inputs |
Last Closing
USD 1.72Change
-0.05 (-2.82)%Market Cap
USD 0.32BVolume
0.02MAnalyst Target
N/AVerdict
Verdict
Itafos Inc. operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, partially acidulated phosphate, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid. It also owns interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Arraias, an integrated phosphate fertilizer project located in Tocantins, Brazil; and Santana, an integrated phosphate mine and fertilizer plant project located in Pará, Brazil. The company was formerly known as MBAC Fertilizer Corp. and changed its name to Itafos Inc. in December 2016. Itafos Inc. is headquartered in Houston, Texas.
Company Website : https://itafos.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| YRAIF | Yara International ASA |
N/A |
USD 8.31B |
| KPLUF | K&S AG |
N/A |
USD 3.14B |
| KNKZF | KWS SAAT SE & Co. KGaA |
N/A |
USD 2.13B |
| BWEL | Boswell J G Co |
+5.00 (+0.92%) |
USD 0.50B |
| VRDR | Verde Resources Inc |
N/A |
USD 0.12B |
| CHYI | Chykingyoung Investment Develo.. |
N/A |
USD 0.11B |
| MGROF | Mustgrow Biologics Corp |
-0.01 (-1.89%) |
USD 0.03B |
| PUBC | PureBase Corp |
N/A |
USD 0.02B |
| EDNSF | Eden Research plc |
N/A |
USD 0.02B |
| VNPKF | Verde Agritech Ltd. |
-0.07 (-19.64%) |
USD 0.02B |
N/A
| Market Performance vs. Industry/Classification (Agricultural Inputs) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 38.71% | 76% | C+ | 79% | B- | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 38.71% | 77% | C+ | 79% | B- | ||
| Trailing 12 Months | |||||||
| Capital Gain | 79.09% | 93% | A | 89% | A- | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 79.09% | 93% | A | 89% | A- | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 2.03% | 53% | F | 48% | F | ||
| Dividend Return | 2.03% | 50% | F | 44% | F | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 31.07% | 85% | B | 69% | C- | ||
| Risk Adjusted Return | 6.53% | 50% | F | 46% | F | ||
| Market Capitalization | 0.32B | 83% | B | 66% | D+ | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
